The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats

    loading  Checking for direct PDF access through Ovid

Abstract

Objective:

To investigate the role of vascular angiotensin II (Ang II) in the vascular thickening of one-kidney, one clip (1-K,1C) hypertensive rats, which show normal plasma renin activity

Methods:

The type 1 Ang II receptor antagonist TCV-116 (1 mg/kg per day), the angiotensin converting enzyme (ACE) inhibitor delapril (20mg/kg per day), hydralazine (20mg/kg per day) or vehicle were administered to four groups of 1-K,1C rats aged 6-10 weeks. Vehicle was also given to uninephrectomized rats

Results:

The aortae of 1-K,1C rats contained significantly higher levels of AngII than those of uninephrectomized rats and showed hypertrophy, but not hyperplasia of their medial smooth muscle cells. Hypertrophy was estimated by immunohistochemical staining of α-actin. Hyperplasia was estimated by DNA content and incorporation of 5-bromo-2'-deoxyuridine. The blood pressure of the 1-K,1C rats was not affected by either TCV-116 or delapril, even at doses sufficient to induce depressor effects in spontaneously hypertensive rats. However, subdepressor doses of TCV-116 and delapril both significantly reduced the a-actin-stained area to 78 and 73%, respectively, of that in the 1-K,1C rats, whereas a depressor dose of hydralazine did not affect the α-actin-stained area. The level of Ang II in the aorta, but not in plasma, was suppressed by delapril but not by hydralazine

Conclusions:

These results suggest strongly that vascular AngII plays a major role in the development of vascular hypertrophy, independently of plasma Ang II, bradykinin and ACE-independent pathways of AngII generation, and in the regulation of blood pressure in this normoreninaemic hypertensive model

Related Topics

    loading  Loading Related Articles